Identification of novel pro-α2(IX) collagen gene mutations in two families with distinctive olgo-epiphyseal forms of multiple epiphyseal dysplasia

被引:48
作者
Holden, P
Canty, EG
Mortier, GR
Zabel, B
Spranger, J
Carr, A
Grant, ME
Loughlin, JA
Briggs, MD
机构
[1] Univ Manchester, Sch Biol Sci, Wellcome Trust Ctr Cell Matrix Res, Manchester M13 9PT, Lancs, England
[2] Ghent Univ Hosp, Dept Med Genet, B-9000 Ghent, Belgium
[3] Johannes Gutenberg Univ Mainz, Childrens Hosp, D-6500 Mainz, Germany
[4] John Radcliffe Hosp, Inst Mol Med, Nuffield Orthopaed Ctr, Oxford OX3 9DU, England
[5] John Radcliffe Hosp, Inst Mol Med, Cellular Genet Grp, Oxford OX3 9DU, England
基金
英国惠康基金;
关键词
D O I
10.1086/302440
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Multiple epiphyseal dysplasia (MED) is a genetically heterogeneous disorder with marked clinical and radiographic variability. Traditionally, the mild "Ribbing" and severe "Fairbank" types have been used to define a broad phenotypic spectrum. Mutations in the gene encoding cartilage oligomeric-matrix protein have been shown to result in several types of MED, whereas mutations in the gene encoding the alpha 2 chain of type IX collagen (COL9A2) have so far been found only in two families with the Fairbank type of MED. Type IX collagen is a heterotrimer of pro-alpha chains derived from three distinct genes-COL9A1, COL9A2, and COL9A3. In this article, we describe two families with distinctive oligo-epiphyseal forms of MED, which are heterozygous for different mutations in the COL9A2 exon 3/intron 3 splice-donor site. Both of these mutations result in the skipping of exon 3 from COL9A2 mRNA, but the position of the mutation in the splice-donor site determines the stability of the mRNA produced from the mutant COL9A2 allele.
引用
收藏
页码:31 / 38
页数:8
相关论文
共 41 条